Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Exp Med ; 213(7): 1307-18, 2016 06 27.
Article in English | MEDLINE | ID: mdl-27270894

ABSTRACT

Human babesiosis is a tick-borne multisystem disease caused by Babesia species of the apicomplexan phylum. Most clinical cases and fatalities of babesiosis are caused by Babesia microti Current treatment for human babesiosis consists of two drug combinations, atovaquone + azithromycin or quinine + clindamycin. These treatments are associated with adverse side effects and a significant rate of drug failure. Here, we provide evidence for radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone (ELQ) prodrug and atovaquone. In vivo efficacy studies in mice using ELQ-271, ELQ-316, and the ELQ-316 prodrug, ELQ-334, demonstrated excellent growth inhibitory activity against the parasite, with potency equal to that of orally administered atovaquone at 10 mg/kg. Analysis of recrudescent parasites after ELQ or atovaquone monotherapy identified genetic substitutions in the Qi or Qo sites, respectively, of the cytochrome bc1 complex. Impressively, a combination of ELQ-334 and atovaquone, at doses as low as 5.0 mg/kg each, resulted in complete clearance of the parasite with no recrudescence up to 122 d after discontinuation of therapy. These results will set the stage for future clinical evaluation of ELQ and atovaquone combination therapy for treatment of human babesiosis.


Subject(s)
Atovaquone/pharmacology , Babesia microti/immunology , Babesiosis/drug therapy , Immunologic Deficiency Syndromes/parasitology , Prodrugs/pharmacology , Quinolones/pharmacology , Animals , Babesiosis/genetics , Babesiosis/immunology , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Mice , Mice, SCID
2.
Transfusion ; 56(8): 2085-99, 2016 08.
Article in English | MEDLINE | ID: mdl-27184823

ABSTRACT

BACKGROUND: Babesia microti is a protozoan parasite responsible for the majority of reported cases of human babesiosis and a major risk to the blood supply. Laboratory screening of blood donors may help prevent transfusion-transmitted babesiosis but there is no Food and Drug Administration-approved screening method yet available. Development of a sensitive, specific, and highly automated B. microti antibody assay for diagnosis of acute babesiosis and blood screening could have an important impact on decreasing the health burden of B. microti infection. STUDY DESIGN AND METHODS: Herein, we take advantage of recent advances in B. microti genomic analyses, field surveys of the reservoir host, and human studies in endemic areas to apply a targeted immunomic approach to the discovery of B. microti antigens that serve as signatures of active or past babesiosis infections. Of 19 glycosylphosphatidylinositol (GPI)-anchored protein candidates (BmGPI1-19) identified in the B. microti proteome, 17 were successfully expressed, printed on a microarray chip, and used to screen sera from uninfected and B. microti-infected mice and humans to determine immune responses that are associated with active and past infection. RESULTS: Antibody responses to various B. microti BmGPI antigens were detected and BmGPI12 was identified as the best biomarker of infection that provided high sensitivity and specificity when used in a microarray antibody assay. CONCLUSION: BmGPI12 alone or in combination with other BmGPI proteins is a promising candidate biomarker for detection of B. microti antibodies that might be useful in blood screening to prevent transfusion-transmitted babesiosis.


Subject(s)
Antigens, Protozoan/immunology , Babesia microti/immunology , Babesiosis/immunology , Biomarkers/analysis , Animals , Genome, Protozoan/genetics , Humans , Kinetics , Mice , Protein Array Analysis
3.
Mol Microbiol ; 99(6): 999-1014, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26585333

ABSTRACT

Phospholipid biosynthesis is critical for the development, differentiation and pathogenesis of several eukaryotic pathogens. Genetic studies have validated the pathway for phosphatidylethanolamine synthesis from phosphatidylserine catalyzed by phosphatidylserine decarboxylase enzymes (PSD) as a suitable target for development of antimicrobials; however no inhibitors of this class of enzymes have been discovered. We show that the Plasmodium falciparum PSD can restore the essential function of the yeast gene in strains requiring PSD for growth. Genetic, biochemical and metabolic analyses demonstrate that amino acids between positions 40 and 70 of the parasite enzyme are critical for proenzyme processing and decarboxylase activity. We used the essential role of Plasmodium PSD in yeast as a tool for screening a library of anti-malarials. One of these compounds is 7-chloro-N-(4-ethoxyphenyl)-4-quinolinamine, an inhibitor with potent activity against P. falciparum, and low toxicity toward mammalian cells. We synthesized an analog of this compound and showed that it inhibits PfPSD activity and eliminates Plasmodium yoelii infection in mice. These results highlight the importance of 4-quinolinamines as a novel class of drugs targeting membrane biogenesis via inhibition of PSD activity.


Subject(s)
Antimalarials/pharmacology , Carboxy-Lyases/antagonists & inhibitors , Carboxy-Lyases/metabolism , Enzyme Inhibitors/pharmacology , Malaria, Falciparum/drug therapy , Plasmodium falciparum/enzymology , Animals , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carboxy-Lyases/genetics , Cloning, Molecular , Female , Malaria, Falciparum/microbiology , Mice , Parasitic Sensitivity Tests , Phosphatidylserines/metabolism , Plasmodium falciparum/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae/genetics
4.
Proc Natl Acad Sci U S A ; 112(38): 11935-40, 2015 Sep 22.
Article in English | MEDLINE | ID: mdl-26351679

ABSTRACT

Identification and genetic validation of new targets from available genome sequences are critical steps toward the development of new potent and selective antimalarials. However, no methods are currently available for large-scale functional analysis of the Plasmodium falciparum genome. Here we present evidence for successful use of morpholino oligomers (MO) to mediate degradation of target mRNAs or to inhibit RNA splicing or translation of several genes of P. falciparum involved in chloroquine transport, apicoplast biogenesis, and phospholipid biosynthesis. Consistent with their role in the parasite life cycle, down-regulation of these essential genes resulted in inhibition of parasite development. We show that a MO conjugate that targets the chloroquine-resistant transporter PfCRT is effective against chloroquine-sensitive and -resistant parasites, causes enlarged digestive vacuoles, and renders chloroquine-resistant strains more sensitive to chloroquine. Similarly, we show that a MO conjugate that targets the PfDXR involved in apicoplast biogenesis inhibits parasite growth and that this defect can be rescued by addition of isopentenyl pyrophosphate. MO-based gene regulation is a viable alternative approach to functional analysis of the P. falciparum genome.


Subject(s)
Morpholinos/pharmacology , Plasmodium falciparum/genetics , Protein Biosynthesis/drug effects , Proteolysis/drug effects , RNA Splicing/drug effects , Animals , Antimalarials/pharmacology , Artemisinins/pharmacology , Chloroquine/pharmacology , Down-Regulation/drug effects , Drug Resistance/drug effects , Flow Cytometry , Genes, Reporter , Hemiterpenes/metabolism , Luciferases/metabolism , Organophosphorus Compounds/metabolism , Parasites/drug effects , Parasites/genetics , Parasites/growth & development , Peptides/pharmacology , Plasmodium falciparum/drug effects , Plasmodium falciparum/growth & development , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, DNA
5.
Sci Rep ; 5: 9064, 2015 Mar 12.
Article in English | MEDLINE | ID: mdl-25761669

ABSTRACT

Phosphoethanolamine methyltransferases (PMTs) catalyze the three-step methylation of phosphoethanolamine to form phosphocholine, a critical step in the synthesis of phosphatidylcholine in a select number of eukaryotes including human malaria parasites, nematodes and plants. Genetic studies in the malaria parasite Plasmodium falciparum have shown that the methyltransferase PfPMT plays a critical function in parasite development and differentiation. The presence of PMT orthologs in other malaria parasites that infect humans and their absence in mammals make them ideal targets for the development of selective antimalarials with broad specificity against different Plasmodium species. Here we describe the X-ray structures and biochemical properties of PMT orthologs from Plasmodium vivax and Plasmodium knowlesi and show that both enzymes are inhibited by amodiaquine and NSC158011, two drugs with potent antimalarial activity. Metabolic studies in a yeast mutant that relies on PkPMT or PvPMT for survival demonstrated that these compounds inhibit phosphatidylcholine biosynthesis from ethanolamine. Our structural and functional data provide insights into the mechanism of catalysis and inhibition of PMT enzymes and set the stage for a better design of more specific and selective antimalarial drugs.


Subject(s)
Methyltransferases/chemistry , Methyltransferases/metabolism , Plasmodium knowlesi/enzymology , Plasmodium vivax/enzymology , Amodiaquine/chemistry , Amodiaquine/pharmacology , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Humans , Kinetics , Methyltransferases/antagonists & inhibitors , Models, Molecular , Protein Conformation , Protein Interaction Domains and Motifs , Structure-Activity Relationship
6.
PLoS One ; 9(10): e107939, 2014.
Article in English | MEDLINE | ID: mdl-25280009

ABSTRACT

The apicomplexan intraerythrocytic parasite Babesia microti is an emerging human pathogen and the primary cause of human babesiosis, a malaria-like illness endemic in the United States. The pathogen is transmitted to humans by the tick vector, Ixodes scapularis, and by transfusion of blood from asymptomatic B. microti-infected donors. Whereas the nuclear and mitochondrial genomes of this parasite have been sequenced, assembled and annotated, its apicoplast genome remained incomplete, mainly due to its low representation and high A+T content. Here we report the complete sequence and annotation of the apicoplast genome of the B. microti R1 isolate. The genome consists of a 28.7 kb circular molecule encoding primarily functions important for maintenance of the apicoplast DNA, transcription, translation and maturation of organellar proteins. Genome analysis and annotation revealed a unique gene structure and organization of the B. microti apicoplast genome and suggest that all metabolic and non-housekeeping functions in this organelle are nuclear-encoded. B. microti apicoplast functions are significantly different from those of the host, suggesting that they might be useful as targets for development of potent and safe therapies for the treatment of human babesiosis.


Subject(s)
Apicoplasts/genetics , Babesia microti/genetics , Genome, Plastid , Molecular Sequence Annotation , Babesia microti/classification , Babesiosis/parasitology , Gene Order , Humans , Molecular Sequence Data , Multigene Family , Phylogeny , Sequence Analysis, DNA
7.
Cell Microbiol ; 16(2): 296-310, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24119134

ABSTRACT

Drosophila haemocytes are essential for the animal to resist Staphylococcus aureus infections. Phagocytosis is a central component of the haemocyte-mediated immune response. It involves regulated interaction between the phagocytic and the endocytic compartments. RabGTPases are pivotal for the membrane trafficking and fusion events, and thus are often targets of intracellular pathogens that subvert phagocytosis. An in vivo screen identified Rab2 and Rab14 as candidates for proteins regulating phagosome maturation. Since Rab14 is often targeted by intracellular pathogens, an understanding of its function during phagocytosis and the overall immune response can give insight into the pathogenesis of intracellular microbes. We generated a Drosophila Rab14 mutant and characterized the resulting immune defects in animals and specifically in haemocytes in response to an S. aureus infection. Haemocyte based immunofluorescence studies indicate that Rab14 is recruited to the phagosome and like Rab7, a well-characterized regulator of the phagocytic pathway, is essential for progression of phagosome maturation. Rab14 mutant haemocytes show impaired recruitment of Rab7 and of a lysosomal marker onto S. aureus phagosomes. The defect in phagocytosis is associated with higher bacterial load and increased susceptibility to S. aureus in the animal.


Subject(s)
Drosophila Proteins/metabolism , Drosophila/microbiology , Hemocytes/immunology , Hemocytes/microbiology , Phagocytosis , Staphylococcus aureus/immunology , rab GTP-Binding Proteins/metabolism , Animals , Drosophila/genetics , Drosophila/immunology , Fluorescent Antibody Technique , Gene Knockout Techniques , Phagosomes/immunology , Phagosomes/metabolism , Protein Transport
8.
Curr Biol ; 23(22): 2319-2324, 2013 Nov 18.
Article in English | MEDLINE | ID: mdl-24210616

ABSTRACT

Glutamate transport is highly regulated as glutamate directly acts as a neurotransmitter and indirectly regulates the synthesis of antioxidants. Although glutamate deregulation has been repeatedly linked to serious human diseases such as HIV infection and Alzheimer's, glutamate's role in the immune system is still poorly understood. We find that a putative glutamate transporter in Drosophila melanogaster, polyphemus (polyph), plays an integral part in the fly's immune response. Flies with a disrupted polyph gene exhibit decreased phagocytosis of microbial-derived bioparticles. When infected with S. aureus, polyph flies show an increase in both susceptibility and bacterial growth. Additionally, the expression of two known glutamate transporters, genderblind and excitatory amino acid transporter 1, in blood cells affects the flies' ability to phagocytose and survive after an infection. Consistent with previous data showing a regulatory role for glutamate transport in the synthesis of the major antioxidant glutathione, polyph flies produce more reactive oxygen species (ROS) as compared to wild-type flies when exposed to S. aureus. In conclusion, we demonstrate that a polyph-dependent redox system in blood cells is necessary to maintain the cells' immune-related functions. Furthermore, our model provides insight into how deregulation of glutamate transport may play a role in disease.


Subject(s)
Blood Cells/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , Glutamic Acid/metabolism , Phagocytosis , Receptors, Glutamate/metabolism , Amino Acid Transport System X-AG/genetics , Amino Acid Transport System X-AG/metabolism , Amino Acid Transport System y+/genetics , Amino Acid Transport System y+/metabolism , Animals , Biological Transport , Blood Cells/immunology , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Drosophila melanogaster/immunology , Drosophila melanogaster/microbiology , Excitatory Amino Acid Transporter 1/genetics , Excitatory Amino Acid Transporter 1/metabolism , Female , Listeria monocytogenes/pathogenicity , Male , Oxidation-Reduction , Reactive Oxygen Species/metabolism , Receptors, Glutamate/genetics , Staphylococcus aureus/pathogenicity
9.
Proc Natl Acad Sci U S A ; 110(45): 18262-7, 2013 Nov 05.
Article in English | MEDLINE | ID: mdl-24145416

ABSTRACT

Efficient transmission of Plasmodium species between humans and Anopheles mosquitoes is a major contributor to the global burden of malaria. Gametocytogenesis, the process by which parasites switch from asexual replication within human erythrocytes to produce male and female gametocytes, is a critical step in malaria transmission and Plasmodium genetic diversity. Nothing is known about the pathways that regulate gametocytogenesis and only few of the current drugs that inhibit asexual replication are also capable of inhibiting gametocyte development and blocking malaria transmission. Here we provide genetic and pharmacological evidence indicating that the pathway for synthesis of phosphatidylcholine in Plasmodium falciparum membranes from host serine is essential for parasite gametocytogenesis and malaria transmission. Parasites lacking the phosphoethanolamine N-methyltransferase enzyme, which catalyzes the limiting step in this pathway, are severely altered in gametocyte development, are incapable of producing mature-stage gametocytes, and are not transmitted to mosquitoes. Chemical screening identified 11 inhibitors of phosphoethanolamine N-methyltransferase that block parasite intraerythrocytic asexual replication and gametocyte differentiation in the low micromolar range. Kinetic studies in vitro as well as functional complementation assays and lipid metabolic analyses in vivo on the most promising inhibitor NSC-158011 further demonstrated the specificity of inhibition. These studies set the stage for further optimization of NSC-158011 for development of a class of dual activity antimalarials to block both intraerythrocytic asexual replication and gametocytogenesis.


Subject(s)
Enzyme Inhibitors/pharmacology , Malaria, Falciparum/transmission , Methyltransferases/metabolism , Plasmodium falciparum/enzymology , Reproduction, Asexual/drug effects , Antimalarials/pharmacology , Female , Fluorescent Antibody Technique , Humans , Malaria, Falciparum/enzymology , Male , Methyltransferases/antagonists & inhibitors , Plasmodium falciparum/growth & development , Radiometry , Serine/metabolism
10.
PLoS One ; 8(9): e72657, 2013.
Article in English | MEDLINE | ID: mdl-24023759

ABSTRACT

Babesia microti is the primary causative agent of human babesiosis, an emerging pathogen that causes a malaria-like illness with possible fatal outcome in immunocompromised patients. The genome sequence of the B. microti R1 strain was reported in 2012 and revealed a distinct evolutionary path for this pathogen relative to that of other apicomplexa. Lacking from the first genome assembly and initial molecular analyses was information about the terminal ends of each chromosome, and both the exact number of chromosomes in the nuclear genome and the organization of the mitochondrial genome remained ambiguous. We have now performed various molecular analyses to characterize the nuclear and mitochondrial genomes of the B. microti R1 and Gray strains and generated high-resolution Whole Genome maps. These analyses show that the genome of B. microti consists of four nuclear chromosomes and a linear mitochondrial genome present in four different structural types. Furthermore, Whole Genome mapping allowed resolution of the chromosomal ends, identification of areas of misassembly in the R1 genome, and genomic differences between the R1 and Gray strains, which occur primarily in the telomeric regions. These studies set the stage for a better understanding of the evolution and diversity of this important human pathogen.


Subject(s)
Babesia microti/genetics , Genome, Mitochondrial/genetics , Genome, Protozoan/genetics , Animals
11.
J Biol Chem ; 288(28): 20558-67, 2013 Jul 12.
Article in English | MEDLINE | ID: mdl-23729665

ABSTRACT

The human malaria parasite Plasmodium falciparum is absolutely dependent on the acquisition of host pantothenate for its development within human erythrocytes. Although the biochemical properties of this transport have been characterized, the molecular identity of the parasite-encoded pantothenate transporter remains unknown. Here we report the identification and functional characterization of the first protozoan pantothenate transporter, PfPAT, from P. falciparum. We show using cell biological, biochemical, and genetic analyses that this transporter is localized to the parasite plasma membrane and plays an essential role in parasite intraerythrocytic development. We have targeted PfPAT to the yeast plasma membrane and showed that the transporter complements the growth defect of the yeast fen2Δ pantothenate transporter-deficient mutant and mediates the entry of the fungicide drug, fenpropimorph. Our studies in P. falciparum revealed that fenpropimorph inhibits the intraerythrocytic development of both chloroquine- and pyrimethamine-resistant P. falciparum strains with potency equal or better than that of currently available pantothenate analogs. The essential function of PfPAT and its ability to deliver both pantothenate and fenpropimorph makes it an attractive target for the development and delivery of new classes of antimalarial drugs.


Subject(s)
Cell Membrane/metabolism , Plasmodium falciparum/metabolism , Protozoan Proteins/metabolism , Symporters/metabolism , Amino Acid Sequence , Animals , Antimalarials/pharmacology , Chloroquine/pharmacology , Drug Resistance/drug effects , Erythrocytes/drug effects , Erythrocytes/parasitology , Erythrocytes/ultrastructure , Genetic Complementation Test , HEK293 Cells , Host-Parasite Interactions/drug effects , Humans , Malaria, Falciparum/parasitology , Microscopy, Fluorescence , Microscopy, Immunoelectron , Molecular Sequence Data , Morpholines/metabolism , Morpholines/pharmacology , Mutation , Pantothenic Acid/metabolism , Pantothenic Acid/pharmacology , Phylogeny , Plasmodium falciparum/genetics , Plasmodium falciparum/physiology , Protozoan Proteins/genetics , Pyrimethamine/pharmacology , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Sequence Homology, Amino Acid , Symporters/classification , Symporters/genetics
12.
Development ; 136(3): 449-59, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19141674

ABSTRACT

In a screen for cell-cycle regulators, we identified a Drosophila maternal effect-lethal mutant that we named ;no poles' (nopo). Embryos from nopo females undergo mitotic arrest with barrel-shaped, acentrosomal spindles during the rapid S-M cycles of syncytial embryogenesis. We identified CG5140, which encodes a candidate RING domain-containing E3 ubiquitin ligase, as the nopo gene. A conserved residue in the RING domain is altered in our EMS-mutagenized allele of nopo, suggesting that E3 ligase activity is crucial for NOPO function. We show that mutation of a DNA checkpoint kinase, CHK2, suppresses the spindle and developmental defects of nopo-derived embryos, revealing that activation of a DNA checkpoint operational in early embryos contributes significantly to the nopo phenotype. CHK2-mediated mitotic arrest has been previously shown to occur in response to mitotic entry with DNA damage or incompletely replicated DNA. Syncytial embryos lacking NOPO exhibit a shorter interphase during cycle 11, suggesting that they may enter mitosis prior to the completion of DNA replication. We show that Bendless (BEN), an E2 ubiquitin-conjugating enzyme, interacts with NOPO in a yeast two-hybrid assay; furthermore, ben-derived embryos arrest with a nopo-like phenotype during syncytial divisions. These data support our model that an E2-E3 ubiquitination complex consisting of BEN-UEV1A (E2 heterodimer) and NOPO (E3 ligase) is required for the preservation of genomic integrity during early embryogenesis.


Subject(s)
Drosophila Proteins/physiology , Drosophila/enzymology , Ubiquitin-Protein Ligases/physiology , Amino Acid Sequence , Animals , Checkpoint Kinase 2 , DNA Damage , Drosophila/embryology , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Embryo, Nonmammalian/physiology , Female , HeLa Cells , Humans , Mitosis , Molecular Sequence Data , Mutation , Protein Binding , Protein Serine-Threonine Kinases/genetics , Spindle Apparatus/genetics , Spindle Apparatus/ultrastructure , Two-Hybrid System Techniques , Ubiquitin-Conjugating Enzymes/metabolism , Ubiquitin-Protein Ligases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...